Agent: 20120129783 - Therapeutic process for the treatment of the metabolic syndrome and associated metabolic disorders: The present invention is directed to a method of treating a patient suffering from the metabolic syndrome and/or related disorders including obesity, Type 2 diabetes, pre-diabetes, hypertension, dyslipidemia, insulin resistance, endothelial dysfunction, pro-inflammatory state, a